168 related articles for article (PubMed ID: 12952290)
1. Gamma interferon transduced 9L gliosarcoma. Cytokine gene therapy and its relevance to cellular therapy with alloreactive cytotoxic T lymphocytes.
Paul DB; Read SB; Kulprathipanja NV; Gomez GG; Kleinschmidt-DeMasters BK; Schiltz PM; Kruse CA
J Neurooncol; 2003; 64(1-2):89-99. PubMed ID: 12952290
[TBL] [Abstract][Full Text] [Related]
2. Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytes.
Schiltz PM; Gomez GG; Read SB; Kulprathipanja NV; Kruse CA
J Interferon Cytokine Res; 2002 Dec; 22(12):1209-16. PubMed ID: 12581494
[TBL] [Abstract][Full Text] [Related]
3. Human alloreactive CTL interactions with gliomas and with those having upregulated HLA expression from exogenous IFN-gamma or IFN-gamma gene modification.
Read SB; Kulprathipanja NV; Gomez GG; Paul DB; Winston KR; Robbins JM; Kruse CA
J Interferon Cytokine Res; 2003 Jul; 23(7):379-93. PubMed ID: 14511464
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation of glioma cells after gene therapy: induction of major histocompatibility complex class I but not class II antigen in vitro.
Parsa AT; Chi JH; Hurley PT; Jeyapalan SA; Bruce JN
Neurosurgery; 2001 Sep; 49(3):681-8; discussion 688-9. PubMed ID: 11523680
[TBL] [Abstract][Full Text] [Related]
5. Microglia phagocytose alloreactive CTL-damaged 9L gliosarcoma cells.
Kulprathipanja NV; Kruse CA
J Neuroimmunol; 2004 Aug; 153(1-2):76-82. PubMed ID: 15265665
[TBL] [Abstract][Full Text] [Related]
6. Induction of acquired immunity in rats that have eliminated intracranial gliosarcoma cells by the expression of herpes simplex virus-thymidine kinase gene and ganciclovir administration.
Iwadate Y; Namba H; Tagawa M; Takenaga K; Sueyoshi K; Sakiyama S
Oncology; 1997; 54(4):329-34. PubMed ID: 9216859
[TBL] [Abstract][Full Text] [Related]
7. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
8. Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model.
Ginzkey C; Eicker SO; Marget M; Krause J; Brecht S; Westphal M; Hugo HH; Mehdorn HM; Steinmann J; Hamel W
Cancer Immunol Immunother; 2010 Apr; 59(4):541-51. PubMed ID: 19798500
[TBL] [Abstract][Full Text] [Related]
9. Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon.
Abdel-Wahab Z; Dar M; Osanto S; Fong T; Vervaert CE; Hester D; Jolly D; Seigler HF
Cancer Gene Ther; 1997; 4(1):33-41. PubMed ID: 9012449
[TBL] [Abstract][Full Text] [Related]
10. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine.
Okada H; Giezeman-Smits KM; Tahara H; Attanucci J; Fellows WK; Lotze MT; Chambers WH; Bozik ME
Gene Ther; 1999 Feb; 6(2):219-26. PubMed ID: 10435106
[TBL] [Abstract][Full Text] [Related]
11. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
12. Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.
Kruse CA; Lillehei KO; Mitchell DH; Kleinschmidt-DeMasters B; Bellgrau D
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9577-81. PubMed ID: 2263613
[TBL] [Abstract][Full Text] [Related]
13. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
[TBL] [Abstract][Full Text] [Related]
14. Effects of gamma-interferon on major histocompatibility complex antigen expression and lymphocytic infiltration in the 9L gliosarcoma brain tumor model: implications for strategies of immunotherapy.
Wen PY; Lampson MA; Lampson LA
J Neuroimmunol; 1992 Jan; 36(1):57-68. PubMed ID: 1735769
[TBL] [Abstract][Full Text] [Related]
15. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats.
Ram Z; Walbridge S; Shawker T; Culver KW; Blaese RM; Oldfield EH
J Neurosurg; 1994 Aug; 81(2):256-60. PubMed ID: 8027810
[TBL] [Abstract][Full Text] [Related]
16. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
[TBL] [Abstract][Full Text] [Related]
17. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents.
Kim JH; Kim SH; Kolozsvary A; Brown SL; Kim OB; Freytag SO
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):861-8. PubMed ID: 7591895
[TBL] [Abstract][Full Text] [Related]
18. Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells.
Mori K; Iwata J; Miyazaki M; Osada H; Tange Y; Yamamoto T; Aiko Y; Tamura M; Shiroishi T
Neurol Med Chir (Tokyo); 2010; 50(7):545-53. PubMed ID: 20671379
[TBL] [Abstract][Full Text] [Related]
19. Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii protein.
Wang Y; Xu M; Che M; Von Hofe E; Abbas A; Kallinteris NL; Lu X; Liss ZJ; Forman JD; Hillman GG
Hum Gene Ther; 2005 Feb; 16(2):187-99. PubMed ID: 15761259
[TBL] [Abstract][Full Text] [Related]
20. Isolation of immunoresistant human glioma cell clones after selection with alloreactive cytotoxic T lymphocytes: cytogenetic and molecular cytogenetic characterization.
Gomez GG; Varella-Garcia M; Kruse CA
Cancer Genet Cytogenet; 2006 Mar; 165(2):121-34. PubMed ID: 16527606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]